Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO 140 in treatment-experienced HIV-1
NCT02483078Phase 3Completed
- Sponsor
- CytoDyn Inc.
- Start
- Oct 2015
- Primary completion
- Feb 2018
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of leronlimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by CytoDyn Inc.. Started Oct 2015; status: completed.
02
Drugs
leronlimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02483078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483078.